Singapore well placed for investments in new drugs, says pharma giant MSD 2022-03-27 March 28, 2022 7:06 AM Singapore set to receive its share of investments into the R&D of new drugs, including mRNA-based vaccines and therapies. Source : https://www.straitstimes.com/business/companies-markets/singapore-well-placed-for-investments-in-new-drugs-says-pharma-giant-msd-0 Share FacebookTwitterPinterestWhatsApp Previous articleNew jobs aplenty, but many only offer up to RM2k salariesNext articleUkraine says Russian forces near Chernobyl could pose new radiation threat Latest Articles DBS, OCBC, UOB shares drop after Q3 results; SATS hit by work pass concerns: Markets this week 2026-11-07 AI slump revives Asia’s forgotten trades from China to India 2026-11-07 Binance CFO Kaiser Ng steps down, Justin Yek named new finance chief 2026-11-07 Ex-ST Engineering, Singtel exec Low Ka Hoe to succeed Tong Yew Heng as Netlink NBN Trust CEO 2026-11-07 Schroders seeks to sell Wisteria Mall in Yishun in bid to offload Singapore properties 2026-11-06 Bitcoin steadies after record hack fallout, US midterms turbulence 2026-11-06